BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 9493958)

  • 1. Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway.
    Nava VE; Rosen A; Veliuona MA; Clem RJ; Levine B; Hardwick JM
    J Virol; 1998 Jan; 72(1):452-9. PubMed ID: 9420245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
    Sané AT; Bertrand R
    Cancer Res; 1998 Jul; 58(14):3066-72. PubMed ID: 9679972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
    Schmitt E; Cimoli G; Steyaert A; Bertrand R
    Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E; Steyaert A; Cimoli G; Bertrand R
    Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of apoptosis induced by anticancer agents in human leukemia cells].
    Yoshida A; Ueda T
    Nihon Rinsho; 1996 Jul; 54(7):1822-7. PubMed ID: 8741673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of the mechanism of DNA fragmentation in apoptosis.
    Walker PR; Sikorska M
    Biochem Cell Biol; 1997; 75(4):287-99. PubMed ID: 9493952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral modulation of the host response via crmA/SPI-2 expression.
    Turner S; Kenshole B; Ruby J
    Immunol Cell Biol; 1999 Jun; 77(3):236-41. PubMed ID: 10361255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine response modifier A (CrmA): a strategically deployed viral weapon.
    Dbaibo GS; Hannun YA
    Clin Immunol Immunopathol; 1998 Feb; 86(2):134-40. PubMed ID: 9473375
    [No Abstract]   [Full Text] [Related]  

  • 11. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.
    Sané AT; Schmitt E; Steyaert A; Meyer D; Bertrand R
    Biochem Cell Biol; 1997; 75(4):359-68. PubMed ID: 9493958
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.